HIGHLIGHTS
- who: Vasilios Liapis from the Translational Oncology Laboratory, Pathology and University of South Australia have published the paper: Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®, in the Journal: (JOURNAL)
- what: The authors aimed to ascertain which emitter Zirconium-89 ([89Zr]ZrIV) or Iodine-124 ([124I]I) was best suited to label chDAB4 for post-chemotherapy PET imaging of tumor-bearing mice and to determine which of two different bifunctional chelators provided optimal tumor imaging by PET using ZrIV-labeled chDAB4. The authors aim to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.